<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04444388</url>
  </required_header>
  <id_info>
    <org_study_id>UEM005</org_study_id>
    <nct_id>NCT04444388</nct_id>
  </id_info>
  <brief_title>Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome</brief_title>
  <official_title>Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome: Effects on Acute and Adaptive Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has recently been suggested that cocoa may improve exercise performance and recovery. This
      study aim to evaluate the plasma and fecal metabolome after 10 weeks of cocoa supplementation
      during the training period in recreational athletes to detect possible metabolites involved
      in the observed benefits of cocoa in athletes
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal microbiota</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of bacterial taxa determined by 16SRNAr gene sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal metabolome profile</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of fecal metabolites, metabolic networks, and metabolic pathways determined by High Pressure Liquid Chromatography-Mass Spectrometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma metabolome profile</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of blood metabolites, metabolic networks, and metabolic pathways activity determined by High Pressure Liquid Chromatography-Mass Spectrometry</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy Athletes</condition>
  <arm_group>
    <arm_group_label>Cocoa group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 g/day of flavonoid-rich defatted cocoa for 10 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 g/day of maltodextrin for 10 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cocoa</intervention_name>
    <description>Sachets of 5 grams of cocoa daily supplementation</description>
    <arm_group_label>Cocoa group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sachets of 5 grams of maltodextrin daily supplementation</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-45 years of age

          -  high physical condition (VO2 ≥ 55 ml/kg/min)

          -  BMI 18-25 kg/m2

        Exclusion Criteria:

          -  antibiotics intake during 3 months prior to the study,

          -  smoking

          -  nutritional complements

          -  ergogenic complements

          -  prebiotics

          -  probiotics

          -  vegetarian or vegan diet

          -  chronic medication

          -  gastrointestinal surgery

          -  Any diagnosed disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mar Larrosa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Europea de Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Europea de Madrid</name>
      <address>
        <city>Villaviciosa de Odón</city>
        <state>Madrid</state>
        <zip>28670</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 18, 2020</study_first_submitted>
  <study_first_submitted_qc>June 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Mar Larrosa</investigator_full_name>
    <investigator_title>Tenure Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

